Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
THO complex subunit 5 (THOC5) is an evolutionarily conserved protein that is a component of the THO subcomplex within the transcription/export (TREX) complex. It participates in coupling transcriptional elongation, mRNA 3′ end processing, and nuclear export of a selective subset of mRNAs, particularly those rapidly induced by extracellular signals such as growth factors and cytokines. THOC5 is critical for the export of immediate-early genes and is essential for stem cell survival and differentiation. Its depletion affects the processing and export of inducible transcripts but not the bulk of steady-state mRNAs. THOC5 is phosphorylated in response to various stimuli, including oncogenic events, and may play a role in cancer development. Genetic studies indicate that it is indispensable for normal stem cell function, and its loss leads to defects in cell differentiation and survival mechanisms[1][2][3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on THO complex subunit 5 (THOC5).